Quick Answer
LEMAITRE VASCULAR INC reported Total Revenue of $100.87 million for fiscal year 2017.
LEMAITRE VASCULAR INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | $57.73M +31.1% |
$44.04M +46.3% |
$30.11M +45.9% |
$20.64M -23.3% |
$26.91M +26.8% |
$21.22M +18.3% |
| Diluted EPS | $2.52 +30.6% |
$1.93 +44.0% |
$1.34 +44.1% |
$0.93 -25.6% |
$1.25 +20.2% |
$1.04 +18.2% |
| Total Assets | $615.69M +11.6% |
$551.82M +59.1% |
$346.78M +11.7% |
$310.48M +6.0% |
$292.80M +15.8% |
$252.81M +34.2% |
| Cash and Equivalents | $28.24M +10.3% |
$25.61M +5.5% |
$24.27M +26.8% |
$19.13M +38.1% |
$13.86M -48.2% |
$26.76M +127.1% |
| Stockholders Equity | $393.52M +16.7% |
$337.29M +13.2% |
$297.90M +11.1% |
$268.20M +5.5% |
$254.15M +47.3% |
$172.57M +16.5% |
| R&D Expense | $14.14M -9.7% |
$15.65M -7.8% |
$16.97M +27.6% |
$13.29M +12.7% |
$11.80M +16.9% |
$10.10M +8.9% |
| Operating Income | $67.91M +30.0% |
$52.26M +42.3% |
$36.71M +36.8% |
$26.83M -26.3% |
$36.42M +26.5% |
$28.79M +35.9% |
| Gross Profit | $178.54M +18.3% |
$150.90M +18.8% |
$127.05M +21.1% |
$104.90M +3.5% |
$101.38M +19.8% |
$84.62M +6.0% |
| Shares Outstanding | 22.77M +1.0% |
22.55M | — | — | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2018 | $24.16M | -2.6% | -10.6% |
| Revenue (ASC 606) | September 30, 2018 | $24.16M | -2.6% | -10.6% |
| Net Income | September 30, 2025 | $17.36M | +55.8% | +26.0% |
| Diluted EPS | September 30, 2025 | $0.75 | +53.1% | +25.0% |
| Total Assets | September 30, 2025 | $598.07M | +58.6% | +3.5% |
| Cash and Equivalents | September 30, 2025 | $25.49M | +21.4% | -6.2% |
| Stockholders Equity | September 30, 2025 | $378.92M | +14.5% | +4.5% |
| R&D Expense | September 30, 2025 | $2.97M | -18.8% | -16.1% |
| Operating Income | September 30, 2025 | $20.31M | +54.5% | +25.8% |
| Gross Profit | September 30, 2025 | $45.95M | +23.6% | +2.2% |
- LEMAITRE VASCULAR INC reported Total Revenue of $100.87 million for fiscal year 2017.
- LEMAITRE VASCULAR INC showed an increase of +13.1% in Total Revenue compared to the prior fiscal year.
- LEMAITRE VASCULAR INC reported Net Income of $57.73 million for fiscal year 2025.
- LEMAITRE VASCULAR INC showed an increase of +31.1% in Net Income compared to the prior fiscal year.
- LEMAITRE VASCULAR INC reported Diluted EPS of $2.52 per share for fiscal year 2025.
- LEMAITRE VASCULAR INC showed an increase of +30.6% in Diluted EPS compared to the prior fiscal year.
- LEMAITRE VASCULAR INC reported Total Assets of $615.69 million for fiscal year 2025.
- LEMAITRE VASCULAR INC showed an increase of +11.6% in Total Assets compared to the prior fiscal year.
- LEMAITRE VASCULAR INC reported Cash and Equivalents of $28.24 million for fiscal year 2025.
- LEMAITRE VASCULAR INC showed an increase of +10.3% in Cash and Equivalents compared to the prior fiscal year.
- LEMAITRE VASCULAR INC reported Stockholders Equity of $393.52 million for fiscal year 2025.
- LEMAITRE VASCULAR INC showed an increase of +16.7% in Stockholders Equity compared to the prior fiscal year.
- LEMAITRE VASCULAR INC reported R&D Expense of $14.14 million for fiscal year 2025.
- LEMAITRE VASCULAR INC showed a decrease of -9.7% in R&D Expense compared to the prior fiscal year.
- LEMAITRE VASCULAR INC reported Operating Income of $67.91 million for fiscal year 2025.
- LEMAITRE VASCULAR INC showed an increase of +30.0% in Operating Income compared to the prior fiscal year.
- LEMAITRE VASCULAR INC reported Gross Profit of $178.54 million for fiscal year 2025.
- LEMAITRE VASCULAR INC showed an increase of +18.3% in Gross Profit compared to the prior fiscal year.
- LEMAITRE VASCULAR INC reported Shares Outstanding of 22.77 million shares for fiscal year 2025.
- LEMAITRE VASCULAR INC showed an increase of +1.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: